BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17977715)

  • 1. Prognostic relevance of disseminated tumour cells in bone marrow of patients with transitional cell carcinoma.
    Hofmann T; Buchner A; Hofstetter A; Stief CG; Oberneder R; Riesenberg R
    Eur J Cancer; 2007 Dec; 43(18):2678-84. PubMed ID: 17977715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and prognostic relevance of disseminated tumor cells in bone marrow of patients with metastatic renal cell carcinoma.
    Buchner A; Riesenberg R; Kotter I; Hofstetter A; Stief C; Oberneder R
    Cancer; 2006 Apr; 106(7):1514-20. PubMed ID: 16518813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated tumor cells in bone marrow of patients with transitional cell carcinoma: immunocytochemical detection and correlation with established prognostic indicators.
    Hofmann T; Riesenberg R; Buchner A; Zimmermann W; Hofstetter A; Oberneder R
    J Urol; 2003 Apr; 169(4):1303-7. PubMed ID: 12629348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and prognostic value of cytokeratin positive tumor cells in bone marrow of patients with renal cell carcinoma.
    Buchner A; Riesenberg R; Kotter I; Crispin A; Hofstetter A; Oberneder R
    J Urol; 2003 Nov; 170(5):1747-51. PubMed ID: 14532768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunocytochemical detection and prognostic significance of epithelial tumor cells in bone marrow of patients with pancreatic carcinoma].
    Thorban S; Roder JD; Pantel K; Siewert JR
    Zentralbl Chir; 1996; 121(6):487-9; discussion 490-2. PubMed ID: 8767337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rating of isolated disseminated tumor cells in bone marrow in comparison with other factors of prognosis in breast carcinoma.
    Leinung S; Würl P; Schönfelder A; Weiss CL; Röder I; Schönfelder M
    Int J Surg Investig; 2000; 2(3):193-202. PubMed ID: 12678519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytological detection of isolated tumour cells in the bone marrow of malignant melanoma patients: a new method for the detection of minimal residual disease.
    Thybusch-Bernhardt A; Klomp HJ; Maas T; Kremer B; Juhl H
    Eur J Surg Oncol; 1999 Oct; 25(5):498-502. PubMed ID: 10527598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of epithelial cells in the blood of patients with gynaecological malignancies.
    Sehouli J; Könsgen D; Nimpsch R; Stengel D; Oskay G; Mustea A; Oertel J; Lichtenegger W
    Anticancer Res; 2003; 23(5b):4133-40. PubMed ID: 14666614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of epithelial carcinoma cells in the blood of patients with gynaecological malignancies.
    Sehouli J; Könsgen D; Nimpsch R; Oskay G; Stengel D; Oertel J; Lichtenegger W; Mustea A
    Anticancer Res; 2003; 23(2A):1093-7. PubMed ID: 12820353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary fibronectin as a predictor of a residual tumour load after transurethral resection of bladder transitional cell carcinoma.
    Li LY; Yang M; Zhang HB; Su XK; Xu WF; Chen Y; Shen ZJ; Gao X
    BJU Int; 2008 Aug; 102(5):566-71. PubMed ID: 18410436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of disseminated tumor cells in bone marrow--currently of no practical therapeutic value].
    Ditsch N; Funke I; Mayer B; Untch M
    MMW Fortschr Med; 2002 Oct; 144(41):37-9. PubMed ID: 12474359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bi-specific immunomagnetic enrichment of micrometastatic tumour cell clusters from bone marrow of cancer patients.
    Woelfle U; Breit E; Zafrakas K; Otte M; Schubert F; Müller V; Izbicki JR; Löning T; Pantel K
    J Immunol Methods; 2005 May; 300(1-2):136-45. PubMed ID: 15907331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunocytochemical detection of cytokeratin positive cells in human bone marrow of gastric and colorectal cancer patients].
    Leinung S; Schönfelder A; Schönfelder M
    Zentralbl Chir; 1998; 123(5):520-4. PubMed ID: 22462221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of cytokeratin-positive bone marrow cells of gastric cancer patients.
    Gretschel S; Schick C; Schneider U; Estevez-Schwarz L; Bembenek A; Schlag PM
    Ann Surg Oncol; 2007 Feb; 14(2):373-80. PubMed ID: 17080240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytochemical detection of occult tumor cells in the bone marrow: prognostic impact on early stages of lung cancer.
    Nosotti M; Tosi D; Palleschi A; Rosso L; Mendogni P; Santambrogio L
    Eur Surg Res; 2008; 41(3):267-71. PubMed ID: 18594145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A European interlaboratory testing of three well-known procedures for immunocytochemical detection of epithelial cells in bone marrow. Results from analysis of normal bone marrow.
    Borgen E; Pantel K; Schlimok G; Müller P; Otte M; Renolen A; Ehnle S; Coith C; Nesland JM; Naume B
    Cytometry B Clin Cytom; 2006 Nov; 70(6):400-9. PubMed ID: 16924637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer.
    Buergy D; Fuchs T; Kambakamba P; Mudduluru G; Maurer G; Post S; Tang Y; Nakada MT; Yan L; Allgayer H
    Cancer; 2009 Oct; 115(20):4667-78. PubMed ID: 19569245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase.
    Borgen E; Beiske K; Trachsel S; Nesland JM; Kvalheim G; Herstad TK; Schlichting E; Qvist H; Naume B
    J Pathol; 1998 Aug; 185(4):427-34. PubMed ID: 9828843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 expression in primary human colorectal cancers and bone marrow micrometastases.
    Sheehan KM; Cahill RA; McGreal G; Steele C; Byrne MF; Kirwan WO; Kay EW; Fitzgerald DJ; Redmond HP; Murray FE
    Dig Liver Dis; 2004 Jun; 36(6):392-7. PubMed ID: 15248379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract.
    Novara G; De Marco V; Dalpiaz O; Gottardo F; Bouygues V; Galfano A; Martignoni G; Patard JJ; Artibani W; Ficarra V
    BJU Int; 2008 Jun; 101(11):1368-74. PubMed ID: 18241252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.